Even more striking is that increased expression of Fsp27 is sufficient to promote hepatic steatosis, with liver morphologies highly similar to those found here in vehicle- and rosiglitazone-treated db/db mice (Guillen et al., 2009). This evidence concerns the gene CIDEC and fatty liver disease.